Arboretum Invests in EQRx, a First-of-its-Kind Biopharmaceutical Company

EQRx announced today that it is launching to create novel, patent-protected medicines at prices that are more affordable for people and sustainable for healthcare systems. EQRx, a first of its kind biotechnology company, is focused on reengineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines.